6
Oct
2026

Douglas Pharmaceuticals Ltd.

Exhibitor at CPHI Milan 2026 stand 5A17, Integrated Pharma
About Us

Douglas Pharmaceuticals is New Zealand’s largest privately owned pharmaceutical and healthcare company, founded in 1967. We have an impressive track record in developing and supplying pharmaceutical products to over 40 countries across a range of therapeutic areas including dermatology, CNS, gastroenterology and oncology.  We also deliver highly personalised softgel CDMO solutions. Our mission is to ‘Improve Lives’ by providing innovative, competitive, and high-quality healthcare solutions.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    New Zealand
  • On CPHI since:
    2015
  • Employees:
    500 - 999
Company types
Pharmaceutical company
View company profile
Contact info
  • +64 9 835 0660
  • Website
  • Central Park Drive and Te Pai Place Henderson, Henderson, 0610, Lincoln, Auckland 8, New Zealand
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 5A17, Integrated Pharma

Products Featured at CPHI Milan 2026

  • Acitretin 10mg & 25mg capsules

    Product Acitretin 10mg & 25mg capsules

    Acitretin is a second-generation retinoid, taken orally and is typically used in the treatment of severe resistant psoriasis. It is a metabolite of etretinate, which was used prior to the introduction of acitretin. Etretinate was discontinued because it had a narrow therapeutic index as well...
  • Alitretinoin 10mg & 30mg softgel capsules

    Product Alitretinoin 10mg & 30mg softgel capsules

    Alitretinoin is a first-generation retinoid and a form of vitamin A. Oral consumption for the treatment of severe chronic hand eczema in adults with proven unresponsiveness to potent topical corticosteroids, oral immunosuppressants and phototherapy. 
  • Bexarotene 75mg softgel capsules

    Product Bexarotene 75mg softgel capsules

    Bexarotene, sold under the brand Targretin, is an antineoplastic (anti-cancer) agent used for the treatment of cutaneous T Cell Lymphoma (CTCL). It is third-generation retinoid
  • Clopine (25 mg/100 tablets/bottle packs)

    Product Clopine (25 mg/100 tablets/bottle packs)

    CLOPINE (clozapine) is an atypical antipsychotic agent. Clozapine is chemically identified as 8-chloro-11-(4-methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine. Clozapine is a yellow crystalline powder. The PhEur monograph for clozapine solubility states that clozapine is freely soluble in methylene chlor...
  • Clopine (25 mg/50 tablets/blister packs)

    Product Clopine (25 mg/50 tablets/blister packs)

    CLOPINE (clozapine) is an atypical antipsychotic agent. Clozapine is chemically identified as 8-chloro-11-(4-methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine. Clozapine is a yellow crystalline powder. The PhEur monograph for clozapine solubility states that clozapine is freely soluble in methylene chlor...

Douglas Pharmaceuticals Ltd. Resources (1)